Meeting Banner
Abstract #2279

Multimodality Neuroimaging Biomarkers in Parkinson’s Disease

Xiaomeng Zhang1, Varsha Mohan1, Dustin Wooten1, Bradley A Hooker1, Yuchuan Zhuang1, Praveen Honhar2, Sophie Holmes2,3, Mika Naganawa2, Mark Dias2, Robert Comley1, Richard E Carson2,4, Sule Tinaz5, David Matuskey2,3,5, Yanping Luo1, and Sjoerd J Finnema1
1Translational Imaging, Neuroscience, Abbvie, North Chicago, IL, United States, 2PET Center, Yale University, New Haven, CT, United States, 3Department of Psychiatry, Yale University, New Haven, CT, United States, 4Department of Biomedical Engineering, Yale University, New Haven, CT, United States, 5Department of Neurology, Yale University, New Haven, CT, United States

Synopsis

Keywords: Parkinson's Disease, MultimodalNeuroimaging is widely used in Parkinson's disease patients to improve diagnosis, provide insights into the natural history of disease, and facilitate the development of new treatments. Different MRI sequences and contrasts have been employed to study structure and function, whilst PET have been used to image receptors, transporters, enzymes and metabolism. In this study we evaluate relationships between pathological and functional markers of neurodegeneration using a range of advanced MRI and PET methods, in the same subjects, cross sectionally and over time. To the best of our knowledge this combination of markers has yet to be reported.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords